All told, Mounjaro and other medications in the GLP-1 family are thought to help lower your set point: the weight your body naturally settles at due to an interplay of genetics, biology, and environment
Cardiovascular (CV) safety was shown to be noninferior to placebo and observations suggest that the CV profile of oral semaglutide is likely to be similar to that of subcutaneous semaglutide
A 2025 systematic review published in Cureus analyzed five studies encompassing 2,905 adult patients using GLP-1 receptor agonists
Kaiser coverage policies change and vary significantly by region, so checking your specific plan's formulary and contacting member services directly is essential
Kapitza, C., Dahl, K., Jacobsen, J